{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:13:47Z","timestamp":1779970427817,"version":"3.53.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501106"],"award-info":[{"award-number":["81501106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MH134"],"award-info":[{"award-number":["ZR2020MH134"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH106"],"award-info":[{"award-number":["ZR2020QH106"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH349"],"award-info":[{"award-number":["ZR2021MH349"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.biopha.2022.113502","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T18:18:19Z","timestamp":1659637099000},"page":"113502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["NT157 inhibits cell proliferation and sensitizes glioma cells to TRAIL-induced apoptosis by up-regulating DR5 expression"],"prefix":"10.1016","volume":"153","author":[{"given":"Ya-jun","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cundong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113502_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/02688697.2021.1907306","article-title":"The prognosis of glioblastoma: a large, multifactorial study","volume":"35","author":"Luo","year":"2021","journal-title":"Br. J. Neurosurg."},{"issue":"17","key":"10.1016\/j.biopha.2022.113502_bib2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2022.113502_bib3","doi-asserted-by":"crossref","unstructured":"W. Chen, R. Zheng, P.D. Baade, S. Zhang, H. Zeng, F. Bray, A. Jemal, X.Q. Yu, J. He, Cancer statistics in China, 2015, CA. Cancer. J. Clin., vol. 66 (no. 2), 2016, pp. 115\u201332.","DOI":"10.3322\/caac.21338"},{"issue":"4","key":"10.1016\/j.biopha.2022.113502_bib4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/ijms19041115","article-title":"Migration\/invasion of malignant gliomas and implications for therapeutic treatment","volume":"19","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113502_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/ijms22010351","article-title":"Molecular mechanisms of treatment resistance in glioblastoma","volume":"22","author":"Ou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2022.113502_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41419-019-1805-9","article-title":"TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ","volume":"10","author":"Lu","year":"2019","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2022.113502_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152950","article-title":"Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5","volume":"62","author":"Fei","year":"2019","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.biopha.2022.113502_bib8","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3390\/biom11111702","article-title":"Can preferentially target prostate cancer stem-like cells via the TRAIL\/DR5 signaling pathway","volume":"11","author":"Seki","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.biopha.2022.113502_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2016.09.021","article-title":"Targeting miRNAs associated with surface expression of death receptors to modulate TRAIL resistance in breast cancer","volume":"383","author":"Zhu","year":"2016","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.biopha.2022.113502_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/cancers11050656","article-title":"Countering TRAIL resistance in melanoma","volume":"11","author":"Eberle","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2022.113502_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc.2017.28","article-title":"Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy","volume":"17","author":"von Karstedt","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2022.113502_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/pharmaceutics13071062","article-title":"Behind the adaptive and resistance mechanisms of cancer stem cells to TRAIL","volume":"13","author":"Quiroz-Reyes","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.biopha.2022.113502_bib13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/cancers11070895","article-title":"Heightened JNK activation and reduced XIAP levels promote TRAIL and sunitinib-mediated apoptosis in colon cancer models","volume":"11","author":"Mahalingam","year":"2019","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.biopha.2022.113502_bib14","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1158\/1535-7163.MCT-13-0842","article-title":"The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer","volume":"13","author":"Ibuki","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.biopha.2022.113502_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1158\/1535-7163.MCT-17-0377","article-title":"Impact of the anticancer drug NT157 on tyrosine kinase signaling networks","volume":"17","author":"Su","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2022.113502_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fendo.2015.00074","article-title":"Preclinical effectiveness of selective inhibitor of IRS-1\/2 NT157 in osteosarcoma cell lines","volume":"6","author":"Garofalo","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2022.113502_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211027916","article-title":"NT157 inhibits HCC migration via downregulating the STAT3\/Jab1 signaling pathway","volume":"20","author":"Yu","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.biopha.2022.113502_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s10637-020-01028-8","article-title":"NT157, an IGF1R-IRS1\/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia","volume":"39","author":"Scopim-Ribeiro","year":"2021","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.biopha.2022.113502_bib19","article-title":"Evaluation of decalcification techniques for rat femurs using HE and immunohistochemical staining","volume":"2017","author":"Liu","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.biopha.2022.113502_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2018.12.014","article-title":"Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway","volume":"444","author":"Xiao","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2022.113502_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12943-018-0788-y","article-title":"Role of non receptor tyrosine kinases in hematological malignances and its targeting by natural products","volume":"17","author":"Siveen","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2022.113502_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ceb.2020.01.016","article-title":"Receptor tyrosine kinase activation: from the ligand perspective","volume":"63","author":"Trenker","year":"2020","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113502_bib23","first-page":"299","article-title":"Protein tyrosine kinases: their roles and their targeting in leukemia","volume":"13","author":"K","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2022.113502_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.biopha.2018.06.110","article-title":"Effects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cells","volume":"106","author":"H\u00e4nze","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113502_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/ATVBAHA.120.314694","article-title":"Arterial thrombotic complications of tyrosine kinase inhibitors","volume":"41","author":"Wu","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2022.113502_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/PPO.0000000000000540","article-title":"DNA damage response in glioblastoma: mechanism for treatment resistance and emerging therapeutic strategies","volume":"27","author":"Bonm","year":"2021","journal-title":"Cancer J."},{"key":"10.1016\/j.biopha.2022.113502_bib27","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/15384047.2015.1046022","article-title":"The interplay between DNA repair and autophagy in cancer therapy","volume":"16","author":"Zhang","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2022.113502_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.128908","article-title":"Co-delivery of ampicillin and \u03b2-lactamase inhibitor by selenium nanocomposite to achieve synergistic anti-infective efficiency through overcoming multidrug resistance","volume":"414","author":"Wang","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biopha.2022.113502_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/978-1-61779-998-3_40","article-title":"Histone H2AX phosphorylation: a marker for DNA damage","volume":"920","author":"Sharma","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2022.113502_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.biopha.2022.113502_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","article-title":"CDK inhibitors: cell cycle regulators and beyond","volume":"14","author":"Besson","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biopha.2022.113502_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dnarep.2018.07.008","article-title":"Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: a double-edged sword protein","volume":"69","author":"Abbastabar","year":"2018","journal-title":"DNA Repair"},{"key":"10.1016\/j.biopha.2022.113502_bib33","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1158\/0008-5472.CAN-16-2055","article-title":"p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy","volume":"76","author":"El-Deiry","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2022.113502_bib34","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1188\/16.CJON.S1.2-8","article-title":"Glioblastoma: overview of disease and treatment","volume":"20","author":"Davis","year":"2016","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.biopha.2022.113502_bib35","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J. Recept. Signal. Transduct. Res."},{"key":"10.1016\/j.biopha.2022.113502_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9675450","article-title":"Hsp90 inhibitor SNX-2112 enhances TRAIL-induced apoptosis of human cervical cancer cells via the ROS-mediated JNK-p53-autophagy-DR5 pathway","volume":"2019","author":"Hu","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2022.113502_bib37","doi-asserted-by":"crossref","first-page":"13191","DOI":"10.1002\/jcp.27991","article-title":"Chrysanthemulide A induces apoptosis through DR5 upregulation via JNK-mediated autophagosome accumulation in human osteosarcoma cells","volume":"234","author":"Zhuo","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2022.113502_bib38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fonc.2019.00461","article-title":"CAPE-pNO2 inhibited the growth and metastasis of triple-negative breast cancer via the EGFR\/STAT3\/Akt\/E-cadherin signaling pathway","volume":"9","author":"Huang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2022.113502_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/1947601913503341","article-title":"Current understanding on EGFR and Wnt\/beta-catenin signaling in glioma and their possible crosstalk","volume":"4","author":"Paul","year":"2013","journal-title":"Genes Cancer"},{"key":"10.1016\/j.biopha.2022.113502_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biocel.2017.06.010","article-title":"Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation","volume":"89","author":"Na","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113502_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2022.113502_bib42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jconrel.2015.09.014","article-title":"Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors","volume":"220","author":"Oh","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2022.113502_bib43","first-page":"35196","article-title":"Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation","volume":"6","author":"Ma","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2022.113502_bib44","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1080\/10717544.2017.1384863","article-title":"TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors","volume":"24","author":"Yang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2022.113502_bib45","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41401-019-0287-8","article-title":"TRAIL-based gene delivery and therapeutic strategies","volume":"40","author":"Zhong","year":"2019","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2022.113502_bib46","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1038\/s41388-021-01697-6","article-title":"Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization","volume":"40","author":"Cing\u00f6z","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.113502_bib47","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7150\/ijbs.30847","article-title":"Andrographolide enhances TRAIL-induced apoptosis via p53-mediated death receptors up-regulation and suppression of the NF-small ka, CyrillicB pathway in bladder cancer cells","volume":"15","author":"Deng","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2022.113502_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2019.01.028","article-title":"Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5","volume":"847","author":"Kim","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113502_bib49","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1038\/s41598-017-08424-w","article-title":"The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5","volume":"7","author":"Oh","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113502_bib50","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1038\/s41388-021-02041-8","article-title":"BET protein degradation triggers DR5-mediated immunogenic cell death to suppress colorectal cancer and potentiate immune checkpoint blockade","volume":"40","author":"Tong","year":"2021","journal-title":"Oncogene"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222008915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222008915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:00:24Z","timestamp":1779969624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222008915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":50,"alternative-id":["S0753332222008915"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113502","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NT157 inhibits cell proliferation and sensitizes glioma cells to TRAIL-induced apoptosis by up-regulating DR5 expression","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113502"}}